# Projected incidence of the five commonest cancers in Kampala, Uganda, to 2030

Source: https://onco.cc/key-papers/paper-asasira-kampala-cancer-projections-2030-bmjopen-2022/  
OnCo record `paper-asasira-kampala-cancer-projections-2030-bmjopen-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Using Kampala Cancer Registry data for 2001 to 2015, the authors projected that cervical, breast and prostate cancer cases will rise by between 33% and 58% by 2026 to 2030, while Kaposi sarcoma and non-Hodgkin lymphoma keep falling.

## Summary

Published as "Infection-related and lifestyle-related cancer burden in Kampala, Uganda: projection of the future cancer incidence up to 2030". Registry incidence for 2001 to 2015 and Uganda Bureau of Statistics population data were projected to 2030 with an age-period-cohort model (Nordpred), with joinpoint regression as a check.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: BMJ Open
- Year: 2022
- DOI: 10.1136/bmjopen-2021-056722
- Authors: Asasira J, Lee S, Tran TXM, Mpamani C, Wabinga H, Jung SY, Chang YJ, Park Y, Cho H
- Findings: Observed age-standardised incidence in 2011 to 2015 was 60.5 per 100,000 women for cervical cancer, 37.6 for breast cancer and 54.2 per 100,000 men for prostate cancer, and 16.4 per 100,000 for Kaposi sarcoma.; Cases were projected to rise by 35.3% for cervical, 57.7% for breast and 33.4% for prostate cancer between 2011 to 2015 and 2026 to 2030.; Kaposi sarcoma cases were projected to fall by 22.6% and non-Hodgkin lymphoma by 37.3%, with Kaposi sarcoma incidence falling from 29.6 per 100,000 in 2001 to 2005 to 10.4 by 2030.
- What it means: Cancer control in Uganda has to plan for more cervical, breast and prostate cancer, not only for the infection-related cancers it has long dealt with.
- Caveats: Projections assume past trends continue and do not model changes in risk factors such as HPV vaccination.; The text describes rates as rising from their 2001 to 2005 values (41.6 per 100,000 men for prostate cancer); the observed 2011 to 2015 rates in the table are used here.

## Sources

- BMJ Open 2022: https://doi.org/10.1136/bmjopen-2021-056722
- PubMed: https://pubmed.ncbi.nlm.nih.gov/35296484/

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Cervical cancer](https://onco.cc/cancers/cervical/), [Kaposi sarcoma](https://onco.cc/cancers/kaposi-sarcoma/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- institutions: [Kampala Cancer Registry](https://onco.cc/institutions/kampala-cancer-registry/), [Uganda Cancer Institute](https://onco.cc/institutions/uganda-cancer-institute/)

---
JSON: https://onco.cc/api/v1/entities/paper-asasira-kampala-cancer-projections-2030-bmjopen-2022.json